Study Investigating Tailored Treatment With Infliximab for Active Crohn's Disease
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
To investigate whether sustained trough levels of IFX can be achieved using IFX (Infliximab)
trough level measurements and adjustment of dosing based upon these levels by means of two
different standardized algorithms in comparison with 'standard of care' IFX treatment and its
effects on clinical and endoscopic outcomes.
Phase:
Phase 4
Details
Lead Sponsor:
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives